Search
for
Sort by
Research 331–360 of 677
- Exosomal microRNA-Based therapies for skin diseases
- Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- The Transgender: Endocrinological Assessment
- Polycystic ovary syndrome: Diagnosis and management
- associations between serum dihydrotestosterone levels, lipid parameters & anthropometric measurements in male patients with type 2 diabetes mellitus
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Clinico-pathological correlation in indian women presenting with cutaneous features of hyperandrogenism: A cross-sectional study
- The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
- Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management
- AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
- Hyper-Androgenic Symptoms and Infertility in Northern Upper Egypt: Impact of Lifestyle Modification
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- Mendelian randomization studies of testosterone exposure: A systematic review
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
- Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort
- Association between hair loss and cardiometabolic diseases in Chinese adults: a cross-sectional analysis in Tianning Cohort
- Repurposing of Drugs for Cardiometabolic Disorders: An Out and Out Cumulation
- PCOS and Cardiometabolic Health over the Reproductive Years
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Cardiometabolic aspects of the polycystic ovary syndrome
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia